Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnosis of Tumors Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 NGS-Based
1.2.3 PCR-Based
1.3 Market by Application
1.3.1 Global Molecular Diagnosis of Tumors Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Diagnostic Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnosis of Tumors Market Perspective (2018-2033)
2.2 Molecular Diagnosis of Tumors Growth Trends by Region
2.2.1 Global Molecular Diagnosis of Tumors Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Molecular Diagnosis of Tumors Historic Market Size by Region (2018-2023)
2.2.3 Molecular Diagnosis of Tumors Forecasted Market Size by Region (2024-2033)
2.3 Molecular Diagnosis of Tumors Market Dynamics
2.3.1 Molecular Diagnosis of Tumors Industry Trends
2.3.2 Molecular Diagnosis of Tumors Market Drivers
2.3.3 Molecular Diagnosis of Tumors Market Challenges
2.3.4 Molecular Diagnosis of Tumors Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnosis of Tumors Players by Revenue
3.1.1 Global Top Molecular Diagnosis of Tumors Players by Revenue (2018-2023)
3.1.2 Global Molecular Diagnosis of Tumors Revenue Market Share by Players (2018-2023)
3.2 Global Molecular Diagnosis of Tumors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Molecular Diagnosis of Tumors Revenue
3.4 Global Molecular Diagnosis of Tumors Market Concentration Ratio
3.4.1 Global Molecular Diagnosis of Tumors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnosis of Tumors Revenue in 2022
3.5 Molecular Diagnosis of Tumors Key Players Head office and Area Served
3.6 Key Players Molecular Diagnosis of Tumors Product Solution and Service
3.7 Date of Enter into Molecular Diagnosis of Tumors Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnosis of Tumors Breakdown Data by Type
4.1 Global Molecular Diagnosis of Tumors Historic Market Size by Type (2018-2023)
4.2 Global Molecular Diagnosis of Tumors Forecasted Market Size by Type (2024-2033)
5 Molecular Diagnosis of Tumors Breakdown Data by Application
5.1 Global Molecular Diagnosis of Tumors Historic Market Size by Application (2018-2023)
5.2 Global Molecular Diagnosis of Tumors Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Molecular Diagnosis of Tumors Market Size (2018-2033)
6.2 North America Molecular Diagnosis of Tumors Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Molecular Diagnosis of Tumors Market Size by Country (2018-2023)
6.4 North America Molecular Diagnosis of Tumors Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Molecular Diagnosis of Tumors Market Size (2018-2033)
7.2 Europe Molecular Diagnosis of Tumors Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Molecular Diagnosis of Tumors Market Size by Country (2018-2023)
7.4 Europe Molecular Diagnosis of Tumors Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnosis of Tumors Market Size (2018-2033)
8.2 Asia-Pacific Molecular Diagnosis of Tumors Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Molecular Diagnosis of Tumors Market Size by Region (2018-2023)
8.4 Asia-Pacific Molecular Diagnosis of Tumors Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Molecular Diagnosis of Tumors Market Size (2018-2033)
9.2 Latin America Molecular Diagnosis of Tumors Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Molecular Diagnosis of Tumors Market Size by Country (2018-2023)
9.4 Latin America Molecular Diagnosis of Tumors Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnosis of Tumors Market Size (2018-2033)
10.2 Middle East & Africa Molecular Diagnosis of Tumors Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Molecular Diagnosis of Tumors Market Size by Country (2018-2023)
10.4 Middle East & Africa Molecular Diagnosis of Tumors Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Molecular Diagnosis of Tumors Introduction
11.1.4 Abbott Laboratories Revenue in Molecular Diagnosis of Tumors Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Roche Holding
11.2.1 Roche Holding Company Detail
11.2.2 Roche Holding Business Overview
11.2.3 Roche Holding Molecular Diagnosis of Tumors Introduction
11.2.4 Roche Holding Revenue in Molecular Diagnosis of Tumors Business (2018-2023)
11.2.5 Roche Holding Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Molecular Diagnosis of Tumors Introduction
11.3.4 Thermo Fisher Scientific Revenue in Molecular Diagnosis of Tumors Business (2018-2023)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Danaher Corporation
11.4.1 Danaher Corporation Company Detail
11.4.2 Danaher Corporation Business Overview
11.4.3 Danaher Corporation Molecular Diagnosis of Tumors Introduction
11.4.4 Danaher Corporation Revenue in Molecular Diagnosis of Tumors Business (2018-2023)
11.4.5 Danaher Corporation Recent Development
11.5 Veracyte
11.5.1 Veracyte Company Detail
11.5.2 Veracyte Business Overview
11.5.3 Veracyte Molecular Diagnosis of Tumors Introduction
11.5.4 Veracyte Revenue in Molecular Diagnosis of Tumors Business (2018-2023)
11.5.5 Veracyte Recent Development
11.6 TBG Diagnostics
11.6.1 TBG Diagnostics Company Detail
11.6.2 TBG Diagnostics Business Overview
11.6.3 TBG Diagnostics Molecular Diagnosis of Tumors Introduction
11.6.4 TBG Diagnostics Revenue in Molecular Diagnosis of Tumors Business (2018-2023)
11.6.5 TBG Diagnostics Recent Development
11.7 Agilient Technologies
11.7.1 Agilient Technologies Company Detail
11.7.2 Agilient Technologies Business Overview
11.7.3 Agilient Technologies Molecular Diagnosis of Tumors Introduction
11.7.4 Agilient Technologies Revenue in Molecular Diagnosis of Tumors Business (2018-2023)
11.7.5 Agilient Technologies Recent Development
11.8 Illumina
11.8.1 Illumina Company Detail
11.8.2 Illumina Business Overview
11.8.3 Illumina Molecular Diagnosis of Tumors Introduction
11.8.4 Illumina Revenue in Molecular Diagnosis of Tumors Business (2018-2023)
11.8.5 Illumina Recent Development
11.9 Genecast
11.9.1 Genecast Company Detail
11.9.2 Genecast Business Overview
11.9.3 Genecast Molecular Diagnosis of Tumors Introduction
11.9.4 Genecast Revenue in Molecular Diagnosis of Tumors Business (2018-2023)
11.9.5 Genecast Recent Development
11.10 Burning Rock Biotech
11.10.1 Burning Rock Biotech Company Detail
11.10.2 Burning Rock Biotech Business Overview
11.10.3 Burning Rock Biotech Molecular Diagnosis of Tumors Introduction
11.10.4 Burning Rock Biotech Revenue in Molecular Diagnosis of Tumors Business (2018-2023)
11.10.5 Burning Rock Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Molecular Diagnosis of Tumors Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of NGS-Based
Table 3. Key Players of PCR-Based
Table 4. Global Molecular Diagnosis of Tumors Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Molecular Diagnosis of Tumors Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Molecular Diagnosis of Tumors Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Molecular Diagnosis of Tumors Market Share by Region (2018-2023)
Table 8. Global Molecular Diagnosis of Tumors Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Molecular Diagnosis of Tumors Market Share by Region (2024-2033)
Table 10. Molecular Diagnosis of Tumors Market Trends
Table 11. Molecular Diagnosis of Tumors Market Drivers
Table 12. Molecular Diagnosis of Tumors Market Challenges
Table 13. Molecular Diagnosis of Tumors Market Restraints
Table 14. Global Molecular Diagnosis of Tumors Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Molecular Diagnosis of Tumors Market Share by Players (2018-2023)
Table 16. Global Top Molecular Diagnosis of Tumors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnosis of Tumors as of 2022)
Table 17. Ranking of Global Top Molecular Diagnosis of Tumors Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Molecular Diagnosis of Tumors Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Molecular Diagnosis of Tumors Product Solution and Service
Table 21. Date of Enter into Molecular Diagnosis of Tumors Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Molecular Diagnosis of Tumors Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Molecular Diagnosis of Tumors Revenue Market Share by Type (2018-2023)
Table 25. Global Molecular Diagnosis of Tumors Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Molecular Diagnosis of Tumors Revenue Market Share by Type (2024-2033)
Table 27. Global Molecular Diagnosis of Tumors Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Molecular Diagnosis of Tumors Revenue Market Share by Application (2018-2023)
Table 29. Global Molecular Diagnosis of Tumors Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Molecular Diagnosis of Tumors Revenue Market Share by Application (2024-2033)
Table 31. North America Molecular Diagnosis of Tumors Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Molecular Diagnosis of Tumors Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Molecular Diagnosis of Tumors Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Molecular Diagnosis of Tumors Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Molecular Diagnosis of Tumors Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Molecular Diagnosis of Tumors Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Molecular Diagnosis of Tumors Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Molecular Diagnosis of Tumors Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Molecular Diagnosis of Tumors Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Molecular Diagnosis of Tumors Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Molecular Diagnosis of Tumors Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Molecular Diagnosis of Tumors Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Molecular Diagnosis of Tumors Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Molecular Diagnosis of Tumors Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Molecular Diagnosis of Tumors Market Size by Country (2024-2033) & (US$ Million)
Table 46. Abbott Laboratories Company Detail
Table 47. Abbott Laboratories Business Overview
Table 48. Abbott Laboratories Molecular Diagnosis of Tumors Product
Table 49. Abbott Laboratories Revenue in Molecular Diagnosis of Tumors Business (2018-2023) & (US$ Million)
Table 50. Abbott Laboratories Recent Development
Table 51. Roche Holding Company Detail
Table 52. Roche Holding Business Overview
Table 53. Roche Holding Molecular Diagnosis of Tumors Product
Table 54. Roche Holding Revenue in Molecular Diagnosis of Tumors Business (2018-2023) & (US$ Million)
Table 55. Roche Holding Recent Development
Table 56. Thermo Fisher Scientific Company Detail
Table 57. Thermo Fisher Scientific Business Overview
Table 58. Thermo Fisher Scientific Molecular Diagnosis of Tumors Product
Table 59. Thermo Fisher Scientific Revenue in Molecular Diagnosis of Tumors Business (2018-2023) & (US$ Million)
Table 60. Thermo Fisher Scientific Recent Development
Table 61. Danaher Corporation Company Detail
Table 62. Danaher Corporation Business Overview
Table 63. Danaher Corporation Molecular Diagnosis of Tumors Product
Table 64. Danaher Corporation Revenue in Molecular Diagnosis of Tumors Business (2018-2023) & (US$ Million)
Table 65. Danaher Corporation Recent Development
Table 66. Veracyte Company Detail
Table 67. Veracyte Business Overview
Table 68. Veracyte Molecular Diagnosis of Tumors Product
Table 69. Veracyte Revenue in Molecular Diagnosis of Tumors Business (2018-2023) & (US$ Million)
Table 70. Veracyte Recent Development
Table 71. TBG Diagnostics Company Detail
Table 72. TBG Diagnostics Business Overview
Table 73. TBG Diagnostics Molecular Diagnosis of Tumors Product
Table 74. TBG Diagnostics Revenue in Molecular Diagnosis of Tumors Business (2018-2023) & (US$ Million)
Table 75. TBG Diagnostics Recent Development
Table 76. Agilient Technologies Company Detail
Table 77. Agilient Technologies Business Overview
Table 78. Agilient Technologies Molecular Diagnosis of Tumors Product
Table 79. Agilient Technologies Revenue in Molecular Diagnosis of Tumors Business (2018-2023) & (US$ Million)
Table 80. Agilient Technologies Recent Development
Table 81. Illumina Company Detail
Table 82. Illumina Business Overview
Table 83. Illumina Molecular Diagnosis of Tumors Product
Table 84. Illumina Revenue in Molecular Diagnosis of Tumors Business (2018-2023) & (US$ Million)
Table 85. Illumina Recent Development
Table 86. Genecast Company Detail
Table 87. Genecast Business Overview
Table 88. Genecast Molecular Diagnosis of Tumors Product
Table 89. Genecast Revenue in Molecular Diagnosis of Tumors Business (2018-2023) & (US$ Million)
Table 90. Genecast Recent Development
Table 91. Burning Rock Biotech Company Detail
Table 92. Burning Rock Biotech Business Overview
Table 93. Burning Rock Biotech Molecular Diagnosis of Tumors Product
Table 94. Burning Rock Biotech Revenue in Molecular Diagnosis of Tumors Business (2018-2023) & (US$ Million)
Table 95. Burning Rock Biotech Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Diagnosis of Tumors Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Molecular Diagnosis of Tumors Market Share by Type: 2022 VS 2033
Figure 3. NGS-Based Features
Figure 4. PCR-Based Features
Figure 5. Global Molecular Diagnosis of Tumors Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Molecular Diagnosis of Tumors Market Share by Application: 2022 VS 2033
Figure 7. Hospitals Case Studies
Figure 8. Diagnostic Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Molecular Diagnosis of Tumors Report Years Considered
Figure 11. Global Molecular Diagnosis of Tumors Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Molecular Diagnosis of Tumors Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Molecular Diagnosis of Tumors Market Share by Region: 2022 VS 2033
Figure 14. Global Molecular Diagnosis of Tumors Market Share by Players in 2022
Figure 15. Global Top Molecular Diagnosis of Tumors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnosis of Tumors as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Molecular Diagnosis of Tumors Revenue in 2022
Figure 17. North America Molecular Diagnosis of Tumors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Molecular Diagnosis of Tumors Market Share by Country (2018-2033)
Figure 19. United States Molecular Diagnosis of Tumors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Molecular Diagnosis of Tumors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Molecular Diagnosis of Tumors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Molecular Diagnosis of Tumors Market Share by Country (2018-2033)
Figure 23. Germany Molecular Diagnosis of Tumors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Molecular Diagnosis of Tumors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Molecular Diagnosis of Tumors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Molecular Diagnosis of Tumors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Molecular Diagnosis of Tumors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Molecular Diagnosis of Tumors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Molecular Diagnosis of Tumors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Molecular Diagnosis of Tumors Market Share by Region (2018-2033)
Figure 31. China Molecular Diagnosis of Tumors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Molecular Diagnosis of Tumors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Molecular Diagnosis of Tumors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Molecular Diagnosis of Tumors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Molecular Diagnosis of Tumors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Molecular Diagnosis of Tumors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Molecular Diagnosis of Tumors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Molecular Diagnosis of Tumors Market Share by Country (2018-2033)
Figure 39. Mexico Molecular Diagnosis of Tumors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Molecular Diagnosis of Tumors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Molecular Diagnosis of Tumors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Molecular Diagnosis of Tumors Market Share by Country (2018-2033)
Figure 43. Turkey Molecular Diagnosis of Tumors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Molecular Diagnosis of Tumors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Abbott Laboratories Revenue Growth Rate in Molecular Diagnosis of Tumors Business (2018-2023)
Figure 46. Roche Holding Revenue Growth Rate in Molecular Diagnosis of Tumors Business (2018-2023)
Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnosis of Tumors Business (2018-2023)
Figure 48. Danaher Corporation Revenue Growth Rate in Molecular Diagnosis of Tumors Business (2018-2023)
Figure 49. Veracyte Revenue Growth Rate in Molecular Diagnosis of Tumors Business (2018-2023)
Figure 50. TBG Diagnostics Revenue Growth Rate in Molecular Diagnosis of Tumors Business (2018-2023)
Figure 51. Agilient Technologies Revenue Growth Rate in Molecular Diagnosis of Tumors Business (2018-2023)
Figure 52. Illumina Revenue Growth Rate in Molecular Diagnosis of Tumors Business (2018-2023)
Figure 53. Genecast Revenue Growth Rate in Molecular Diagnosis of Tumors Business (2018-2023)
Figure 54. Burning Rock Biotech Revenue Growth Rate in Molecular Diagnosis of Tumors Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed